Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Ilaria
Ilaria Bettinelli, Ispra (varese) IT
| Patent application number | Description | Published |
|---|---|---|
| 20120028931 | HETEROCYCLIC M-GLU5 ANTAGONISTS - Compounds I | 02-02-2012 |
Ilaria Bientinesi, Verona IT
| Patent application number | Description | Published |
|---|---|---|
| 20080262234 | Process for Preparing N, N-Substituted Carbamoyl Halides - The present invention relates to a new and useful process for preparing N,N-substituted carbamoyl halides from secondary amines, carbon dioxide, trialkylsilyl chloride and a halogenating agent. | 10-23-2008 |
Ilaria Ciattaglia, Munich DE
| Patent application number | Description | Published |
|---|---|---|
| 20110300054 | METHOD OF USING AN OXYGEN WASTE STREAM AS AN OXIDIZER FEED GAS STREAM - A method for producing carbon dioxide using the waste gas oxygen stream from an air separation unit producing nitrogen as the oxygen feed. The oxygen is fed to an autothermal reformation or partial oxidation unit to produce synthesis gas which is subjected to a shift reaction to produce hydrogen and carbon dioxide. The carbon dioxide is separated and recovered and can be employed in an enhanced oil recovery operation. | 12-08-2011 |
Ilaria Deambrosis, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20110144038 | HUMAN CD154-BINDING SYNTHETIC PEPTIDE AND USES THEREOF - The invention refers to a synthetic peptide comprising an amino acid sequence of seven residues in length, preferably flanked by 2 cysteine residues at both ends, which is capable of specifically recognizing human CD154 and blocking CD40:CD154 interaction, thereby inhibiting the biological effects depending on such interaction. The peptide of the invention, which is preferably in a cyclic form, is suitable for use for diagnostic and therapeutic applications, especially for the diagnosis and therapy of tumor, inflammatory diseases and transplant rejection. | 06-16-2011 |
Ilaria Ferlenghi, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20100074923 | PURIFICATION OF BACTERIAL ANTIGENS - Presented are methods of isolation of pili and pilus-like structures from Gram-positive bacteria including | 03-25-2010 |
| 20110275132 | PURIFICATION OF BACTERIAL ANTIGENS - Presented are methods of isolation of pili and pilus-like structures from Gram-positive bacteria including | 11-10-2011 |
Ilaria Gelmi, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20110031567 | PROCESS FOR MANUFACTURING MEMS DEVICES HAVING BURIED CAVITIES AND MEMS DEVICE OBTAINED THEREBY - A process for manufacturing a MEMS device, wherein a bottom silicon region is formed on a substrate and on an insulating layer; a sacrificial region of dielectric is formed on the bottom region; a membrane region, of semiconductor material, is epitaxially grown on the sacrificial region; the membrane region is dug down to the sacrificial region so as to form through apertures; the side wall and the bottom of the apertures are completely coated in a conformal way with a porous material layer; at least one portion of the sacrificial region is selectively removed through the porous material layer and forms a cavity; and the apertures are filled with filling material so as to form a monolithic membrane suspended above the cavity. | 02-10-2011 |
Ilaria Gorga, Rome IT
| Patent application number | Description | Published |
|---|---|---|
| 20120137124 | MULTI-VERSION MESSAGE CONDITION BASED DELIVERY - A method for condition-based message delivery may be provided. The method may comprise receiving a first message, a second message and a condition on a sending message server at a first time instance. The method may also comprise encrypting the first message with a first encryption key and encrypting the second message with a second encryption key, as well as sending the first and the second message to a recipient message system. Moreover, the method may comprise receiving a request from the recipient message system at a second time instance for sending one of the decryption keys corresponding to either the first or the second encryption key, and sending the first decryption key or the second decryption key depending on the condition to the recipient message system. | 05-31-2012 |
Ilaria Mormino, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20100234616 | METHOD FOR THE PREPARATION OF RUFINAMIDE - The invention provides a novel process for the regioselective preparation of a compound of formula (I) | 09-16-2010 |
Ilaria Muratori, Milano IT
| Patent application number | Description | Published |
|---|---|---|
| 20120111729 | CONTINUOUS ELECTROLYTIC SURFACE FINISHING OF BARS - An apparatus ( | 05-10-2012 |
Ilaria Paolinl, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20110028409 | DETECTION OF ANTI-RIBOSOMAL P PROTEIN ANTIBODIES BY MEANS OF SYNTHETIC PEPTIDES - The present invention refers peptides and methods for the identification of diagnostic antibodies in auto-immune diseases such as Systemic Lupus Erythematosus (SLE), and therefore useful tools for diagnosis or therapeutic treatment of SLE. | 02-03-2011 |
Ilaria Pertot, Tesero IT
| Patent application number | Description | Published |
|---|---|---|
| 20110020286 | TRICHODERMA ATROVIRIDE SC1 FOR BIOCONTROL OF FUNGAL DISEASES IN PLANTS - An embodiment of the present invention is a | 01-27-2011 |
Ilaria Sciamanna, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20090203892 | Retrotransposon Inhibition in Therapy - RNA interference is useful in the treatment of cancerous lesions, wherein the RNA recognises a portion of at least one LINE-I repeat element. | 08-13-2009 |
Ilaria Stanghellini, Baltimore, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100105043 | METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Described herein is Zscan4, a gene exhibiting 2-cell embryonic stage and embryonic stem cell specific expression. Identification of nine Zscan4 co-expressed genes is also described Inhibition of Zscan4 expression inhibits the 2-cell to 4-cell embryonic transition and prevents blastocyst implantation, expansion and outgrowth. Provided herein are methods of inhibiting differentiation of a stem cell, promoting blastocyst outgrowth of embryonic stem cells and identifying a subpopulation of stem cells expressing Zscan4. Further described is the identification of Trim43 as a gene exhibiting morula-specific expression. Also provided are isolated expression vectors comprising a Zscan4 promoter, or a Trim43 promoter operably linked to a heterologous polypeptide and uses thereof. Further provided are transgenic animals comprising transgenes encoding marker proteins operably linked to Zscan4 and Trim43 promoters. | 04-29-2010 |
| 20120129161 | METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION - Described herein is Zscan4, a gene exhibiting 2-cell embryonic stage and embryonic stem cell specific expression. Identification of nine Zscan4 co-expressed genes is also described. Inhibition of Zscan4 expression inhibits the 2-cell to 4-cell embryonic transition and prevents blastocyst implantation, expansion and outgrowth. Provided herein are methods of inhibiting differentiation of a stem cell, promoting blastocyst outgrowth of embryonic stem cells and identifying a subpopulation of stem cells expressing Zscan4. Further described is the identification of Trim43 as a gene exhibiting morula-specific expression. Also provided are isolated expression vectors comprising a Zscan4 promoter, or a Trim43 promoter operably linked to a heterologous polypeptide and uses thereof. Further provided are transgenic animals comprising transgenes encoding marker proteins operably linked to Zscan4 and Trim43 promoters. | 05-24-2012 |